European Archives - Page 934 of 1212 - European Medical Journal

Short-Term ART Cessation is Supported in Clinical Trials

DISCONTINUATION of HIV treatment for a short period does not cause the irreversible effects that were initially thought, according to results from a…

New Contact Lens Developed that Measures Glucose Levels in Diabetes Patients

Glucose levels can be measured by a new soft contact lens that has a glucose monitor embedded into it. Read the article and find out more.

Sofosbuvir Shows Potential for Treating Zika Virus

ZIKA-INFECTED individuals might one day benefit from treatment with a drug used to treat hepatitis C patients, according to researchers at the University…

Revising Guidelines on Drinking Could Reduce Incidences of Severe Liver Disease in Men

CURRENT recommendations for the safe cut-off of alcohol consumption may need to be revised after a study in Sweden suggested that levels of drinking…

Innovative Operating Table Developed to Enhance Surgical Procedures

A new operating table has been developed which should assist surgeons in undertaking a wide variety of surgical procedures

Preventing Disabilities in Children Caused by Leprosy

This year, World Leprosy Day falls on Sunday 28th January. The occasion has been observed since 1954 and aims to raise awareness, providing more people…

Thrombectomies Can Improve Outcomes in More Stroke Patients than Previously Believed

OUTCOMES can be dramatically improved through the use of thrombectomy in a far greater number of stroke patients than previously thought. This was…

Left Side of the Brain Shown to Control Verbal Expression of Semantic Memory

VERBAL expression of long-term semantic memory has been discovered to be controlled by the left side of the brain by a team led by researchers from the…

EMJ

News Update: CALM Study Results

A presentation summarising the design and results from the CALM study, which compared the tight control approach with symptom-driven care in patients…

EMJ

Treating to Target in Inflammatory Bowel Disease: At What Cost?

A presentation summarising the clinical benefits of the treat to target approach in inflammatory bowel disease, particularly reflecting on the changes in…